Hypoparathyroidism Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • ID: 4542562
  • Report
  • 66 pages
  • Knowledge Sourcing Intelligence LLP
1 of 4

FEATURED COMPANIES

  • Amorphical Ltd.
  • Ascendis Pharma
  • EnteraBio Ltd.
  • Pharis Pharmaceuticals
  • MORE
Hypoparathyroidism Pipeline Analysis report covers 5 drugs currently in different phases of development. Hypoparathyroidism is a rare condition that arises due to inadequate production, secretion and activity of parathyroid hormone. The decreased level of parathyroid hormone leads to low calcium levels as well as low potassium levels in the blood. The condition may be caused by injury to or removal of the parathyroid glands, genetic disorders such as DiGeorge syndrome: cancer radiation treatments or insufficient magnesium levels in the body. Symptoms include: muscle spasms, muscle aches or cramps, tingling, burning, or numbness in the fingertips, toes, and lips, fatigue or weakness, painful menstruation, depression or anxiety and brittle nails.

The report provides Hypoparathyroidism treatment drugs by company, phases of development including products in early discovery stage and NDA filing, molecule type, route of administration and region. The report will help to evaluate the collaboration, in-licensing and out-licensing opportunities, formulating business development strategies and tracking the activities of the key market players. Epidemiology, major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Various databases (for patents and Clinical Trials), studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.

Major industry players profiled as part of the report are EnteraBio Ltd., Amorphical Ltd., Ascendis Pharma, Chugai Pharmaceutical Co., Ltd. and Pharis Pharmaceuticals.

Scope:
  • By Company
  • By Phase
  • By Molecule Type
  • By Region
  • By Route of Administration
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amorphical Ltd.
  • Ascendis Pharma
  • EnteraBio Ltd.
  • Pharis Pharmaceuticals
  • MORE
1. Introduction
1.1. Research Methodology
1.2. Research Scope
1.2.1. Analysis by Company
1.2.2. Analysis by Phase
1.2.3. By Molecule Type
1.2.4. By region

2. Disease Overview
2.1.1. Introduction
2.1.2. Classification
2.1.3. Symptoms
2.1.4. Causes
2.1.5. Diagnoses
2.1.6. Treatment
2.1.7. Epidemiology

3. Executive Summary

4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities

5. Pipeline Analysis/Outlook
5.1. Analysis by Company
5.2. Analysis by Phase
5.2.1. Phase of Development
5.2.1.1. Introduction
5.2.1.1.1. Drug Profiling
  • Drug Name
  • Generic Name
  • Synonyms
  • Company
  • Collaborator
  • Route of administration
  • Target
  • Mechanism of Action
  • Technology
  • Molecule type
  • CAS Number
  • Weight
  • Chemical Formula
  • IUPAC name
  • ATC code
5.2.1.1.2. Strategic Developments
5.2.1.1.3. Clinical trials
5.2.1.1.4. Clinical trial results
5.2.1.1.5. Patents
5.2.1.1.6. Technology
5.2.2. Comparative Analysis for Trials by Phase (Pie, Bar graph)
5.3. By Molecule type
5.4. Analysis by Region

6. Company profiling
6.1. EnteraBio Ltd.
6.1.1. Introduction
6.1.2. Financials
6.1.3. Products and Services
6.1.4. SWOT
6.2. Amorphical Ltd.
6.2.1. Introduction
6.2.2. Financials
6.2.3. Products and Services
6.2.4. SWOT
6.3. Ascendis Pharma
6.3.1. Introduction
6.3.2. Financials
6.3.3. Products and Services
6.3.4. SWOT
6.4. Chugai Pharmaceutical Co., Ltd.
6.4.1. Introduction
6.4.2. Financials
6.4.3. Products and Services
6.4.4. SWOT
6.5. Pharis Pharmaceuticals
6.5.1. Introduction
6.5.2. Financials
6.5.3. Products and Services
6.5.4. SWOT
List of Tables
List of Figures
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • EnteraBio Ltd.
  • Amorphical Ltd.
  • Ascendis Pharma
  • Chugai Pharmaceutical Co., Ltd.
  • Pharis Pharmaceuticals
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll